NPI: 1992894125 · LAKEWOOD, CA 90713 · Community Health Clinic/Center · NPI assigned 10/12/2006
Authorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | PAHL, LINDA (CFO) |
| NPI Enumeration Date | 10/12/2006 |
Other providers sharing the same authorized official: PAHL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,067 | $929K |
| 2019 | 10,501 | $504K |
| 2020 | 8,608 | $281K |
| 2021 | 12,253 | $592K |
| 2022 | 8,555 | $418K |
| 2023 | 16,771 | $922K |
| 2024 | 14,429 | $843K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6,829 | 6,349 | $832K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3,465 | 3,273 | $685K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,716 | 1,678 | $537K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 4,618 | 4,444 | $433K |
| J3490 | Unclassified drugs | 11,201 | 9,958 | $380K |
| S4993 | Contraceptive pills for birth control | 3,094 | 3,090 | $338K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,612 | 1,582 | $304K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 501 | 501 | $194K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 183 | 183 | $160K |
| 87806 | 4,331 | 3,228 | $109K | |
| 58300 | 612 | 300 | $54K | |
| A4267 | Contraceptive supply, condom, male, each | 9,288 | 9,149 | $53K |
| 99401 | 2,293 | 2,282 | $44K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,709 | 1,661 | $43K |
| 11976 | 683 | 344 | $39K | |
| 11981 | 171 | 171 | $37K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 582 | 517 | $34K |
| S5000 | Prescription drug, generic | 4,859 | 4,601 | $32K |
| 81025 | 8,880 | 8,650 | $31K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,744 | 1,691 | $28K |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 1,930 | 1,930 | $25K |
| 83986 | 8,234 | 6,649 | $22K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 5,017 | 4,874 | $18K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 43 | 43 | $15K |
| J7300 | Intrauterine copper contraceptive (paragard) | 16 | 16 | $11K |
| 99000 | 2,947 | 2,932 | $10K | |
| 86703 | 492 | 385 | $5K | |
| 81002 | 2,119 | 2,065 | $4K | |
| 58301 | 78 | 39 | $3K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 591 | 584 | $2K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 141 | 141 | $2K |
| 87210 | 444 | 436 | $1K | |
| 99201 | 12 | 12 | $1K | |
| 82120 | 427 | 420 | $1K | |
| 99402 | 27 | 27 | $858.33 | |
| 86592 | 235 | 235 | $584.35 | |
| S0190 | Mifepristone, oral, 200 mg | 13 | 13 | $347.66 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 34 | 33 | $184.84 |
| S0191 | Misoprostol, oral, 200 mcg | 13 | 13 | $24.30 |